Εμφάνιση απλής εγγραφής

dc.creatorSiristatidis C., Dafopoulos K., Vrantza T., Salamalekis G., Basios G., Vogiatzi P., Pergialiotis V., Papantoniou N.en
dc.date.accessioned2023-01-31T09:57:09Z
dc.date.available2023-01-31T09:57:09Z
dc.date.issued2017
dc.identifier10.1080/09513590.2017.1296128
dc.identifier.issn09513590
dc.identifier.urihttp://hdl.handle.net/11615/79054
dc.description.abstractMild controlled ovarian hyperstimulation (COH) protocols combining clomiphene citrate (CC) or letrozole with gonadotropins were introduced as an effective alternative of conventional COH in normal responders undergoing IVF/ICSI. In this case–control study, we compared 41 participants treated with a mild stimulation protocol receiving gonadotropins combined with either CC (n = 24) or letrozole (n = 17) with 71 subfertile participants with matching baseline characteristics, conforming with the same inclusion criteria and treated with a conventional antagonist protocol. Live birth was determined in reduced rates in the study group compared to the control group, reaching marginal statistical significance [4/41 versus 19/71, p = 0.050], as also in the respective number of clinical pregnancies [6/41 versus 22/71, p = 0.054], although the incidence of miscarriage was similar for both groups [2/41 versus 5/71, p = 0.714]. Most of the secondary parameters examined, favored the conventional antagonist protocol. There was no difference in any of the outcomes reported between the three different stimulation groups in post-hoc analysis. Mild stimulation regimens with the aid of either CC or letrozole employing GnRH antagonists do not seem to constitute an equally effective method as compared to the conventional antagonist protocol to be offered in good prognosis subfertile women seeking an induced cycle toward IVF/ICSI. © 2017 Informa UK Limited, trading as Taylor & Francis Group.en
dc.language.isoenen
dc.sourceGynecological Endocrinologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85014561779&doi=10.1080%2f09513590.2017.1296128&partnerID=40&md5=c93bdb4f58527a4b0efabdadc7bf3e66
dc.subjectcetrorelixen
dc.subjectchorionic gonadotropinen
dc.subjectclomifene citrateen
dc.subjectganirelixen
dc.subjectgonadotropin derivativeen
dc.subjectletrozoleen
dc.subjectrecombinant follitropinen
dc.subjectclomifeneen
dc.subjectfertility promoting agenten
dc.subjectletrozoleen
dc.subjectnitrileen
dc.subjecttriazole derivativeen
dc.subjectadulten
dc.subjectArticleen
dc.subjectcase control studyen
dc.subjectcontrolled studyen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjectin vitro fertilizationen
dc.subjectincidenceen
dc.subjectlive birthen
dc.subjectmajor clinical studyen
dc.subjectovary hyperstimulationen
dc.subjectpregnancyen
dc.subjectpriority journalen
dc.subjectprognosisen
dc.subjectspontaneous abortionen
dc.subjectcomparative studyen
dc.subjectin vitro fertilizationen
dc.subjectintracytoplasmic sperm injectionen
dc.subjectovulation inductionen
dc.subjectpregnancy rateen
dc.subjectproceduresen
dc.subjecttreatment outcomeen
dc.subjectyoung adulten
dc.subjectAdulten
dc.subjectCase-Control Studiesen
dc.subjectClomipheneen
dc.subjectFemaleen
dc.subjectFertility Agents, Femaleen
dc.subjectFertilization in Vitroen
dc.subjectHumansen
dc.subjectNitrilesen
dc.subjectOvulation Inductionen
dc.subjectPregnancyen
dc.subjectPregnancy Rateen
dc.subjectSperm Injections, Intracytoplasmicen
dc.subjectTreatment Outcomeen
dc.subjectTriazolesen
dc.subjectYoung Adulten
dc.subjectTaylor and Francis Ltden
dc.titleMild versus conventional antagonist ovarian stimulation protocols in expected normal responders undergoing IVF/ICSI: a case–control studyen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής